Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events

  • Paul M Ridker
    From the Center for Cardiovascular Disease Prevention and the Department of Medicine (P.M.R.), Brigham and Women’s Hospital, Boston, Mass; the Divisions of Clinical Pharmacology (N.J.B.) and Cardiovascular Medicine (D.E.V.), Vanderbilt University Medical Center, Nashville, Tenn; the Division of Cardiology (D.G.H.), Emory University, Atlanta, Ga; and the Division of Cardiovascular Medicine (J.L.M.), University of Arkansas, Little Rock, Ark.
  • Nancy J. Brown
    From the Center for Cardiovascular Disease Prevention and the Department of Medicine (P.M.R.), Brigham and Women’s Hospital, Boston, Mass; the Divisions of Clinical Pharmacology (N.J.B.) and Cardiovascular Medicine (D.E.V.), Vanderbilt University Medical Center, Nashville, Tenn; the Division of Cardiology (D.G.H.), Emory University, Atlanta, Ga; and the Division of Cardiovascular Medicine (J.L.M.), University of Arkansas, Little Rock, Ark.
  • Douglas E. Vaughan
    From the Center for Cardiovascular Disease Prevention and the Department of Medicine (P.M.R.), Brigham and Women’s Hospital, Boston, Mass; the Divisions of Clinical Pharmacology (N.J.B.) and Cardiovascular Medicine (D.E.V.), Vanderbilt University Medical Center, Nashville, Tenn; the Division of Cardiology (D.G.H.), Emory University, Atlanta, Ga; and the Division of Cardiovascular Medicine (J.L.M.), University of Arkansas, Little Rock, Ark.
  • David G. Harrison
    From the Center for Cardiovascular Disease Prevention and the Department of Medicine (P.M.R.), Brigham and Women’s Hospital, Boston, Mass; the Divisions of Clinical Pharmacology (N.J.B.) and Cardiovascular Medicine (D.E.V.), Vanderbilt University Medical Center, Nashville, Tenn; the Division of Cardiology (D.G.H.), Emory University, Atlanta, Ga; and the Division of Cardiovascular Medicine (J.L.M.), University of Arkansas, Little Rock, Ark.
  • Jawahar L. Mehta
    From the Center for Cardiovascular Disease Prevention and the Department of Medicine (P.M.R.), Brigham and Women’s Hospital, Boston, Mass; the Divisions of Clinical Pharmacology (N.J.B.) and Cardiovascular Medicine (D.E.V.), Vanderbilt University Medical Center, Nashville, Tenn; the Division of Cardiology (D.G.H.), Emory University, Atlanta, Ga; and the Division of Cardiovascular Medicine (J.L.M.), University of Arkansas, Little Rock, Ark.

収録刊行物

  • Circulation

    Circulation 109 (25_suppl_1), IV-6-, 2004-06-29

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (18)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ